Literature DB >> 30461695

Obstetric Care Consensus No. 7: Placenta Accreta Spectrum.

.   

Abstract

Placenta accreta spectrum, formerly known as morbidly adherent placenta, refers to the range of pathologic adherence of the placenta, including placenta increta, placenta percreta, and placenta accreta. The most favored hypothesis regarding the etiology of placenta accreta spectrum is that a defect of the endometrial-myometrial interface leads to a failure of normal decidualization in the area of a uterine scar, which allows abnormally deep placental anchoring villi and trophoblast infiltration. Maternal morbidity and mortality can occur because of severe and sometimes life-threatening hemorrhage, which often requires blood transfusion. Although ultrasound evaluation is important, the absence of ultrasound findings does not preclude a diagnosis of placenta accreta spectrum; thus, clinical risk factors remain equally important as predictors of placenta accreta spectrum by ultrasound findings. There are several risk factors for placenta accreta spectrum. The most common is a previous cesarean delivery, with the incidence of placenta accreta spectrum increasing with the number of prior cesarean deliveries. Antenatal diagnosis of placenta accreta spectrum is highly desirable because outcomes are optimized when delivery occurs at a level III or IV maternal care facility before the onset of labor or bleeding and with avoidance of placental disruption. The most generally accepted approach to placenta accreta spectrum is cesarean hysterectomy with the placenta left in situ after delivery of the fetus (attempts at placental removal are associated with significant risk of hemorrhage). Optimal management involves a standardized approach with a comprehensive multidisciplinary care team accustomed to management of placenta accreta spectrum. In addition, established infrastructure and strong nursing leadership accustomed to managing high-level postpartum hemorrhage should be in place, and access to a blood bank capable of employing massive transfusion protocols should help guide decisions about delivery location.

Entities:  

Mesh:

Year:  2018        PMID: 30461695     DOI: 10.1097/AOG.0000000000002983

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  28 in total

Review 1.  Placenta accreta spectrum.

Authors:  Valerie Bloomfield; Stacey Rogers; Nicholas Leyland
Journal:  CMAJ       Date:  2020-08-24       Impact factor: 8.262

Review 2.  Extravillous trophoblast migration and invasion: Impact of environmental chemicals and pharmaceuticals.

Authors:  Cassandra Meakin; Emily S Barrett; Lauren M Aleksunes
Journal:  Reprod Toxicol       Date:  2021-11-25       Impact factor: 3.143

3.  When the balloon goes up, blood transfusion goes down: a pilot study of REBOA in placenta accreta spectrum disorders.

Authors:  Yevgeniya J M Ioffe; Sigrid Burruss; Ruofan Yao; Beverly Tse; Alicia Cryer; Kaushik Mukherjee; Linda J Hong
Journal:  Trauma Surg Acute Care Open       Date:  2021-08-13

4.  Placenta accreta spectrum on an unscarred uterus in the third-trimester pregnancy: two rare cases at Tu Du Hospital in Vietnam.

Authors:  Anh Dinh Bao Vuong; Xuan Trang Nguyen; Phuc Nhon Nguyen
Journal:  Int J Surg Case Rep       Date:  2022-09-07

5.  Elevated serum YKL-40 levels as a diagnostic and prognostic marker in the placenta accreta spectrum.

Authors:  Neslihan Bayramoğlu Tepe; Denizhan Bayramoglu; İbrahim Taşkum
Journal:  Turk J Obstet Gynecol       Date:  2022-06-27

6.  Outcomes of prophylactic abdominal aortic balloon occlusion in patients with placenta previa accreta: a propensity score matching analysis.

Authors:  Huifen Yin; Rong Hu
Journal:  BMC Pregnancy Childbirth       Date:  2022-06-20       Impact factor: 3.105

7.  FIGO recommendations on the management of postpartum hemorrhage 2022.

Authors:  Maria Fernanda Escobar; Anwar H Nassar; Gerhard Theron; Eythan R Barnea; Wanda Nicholson; Diana Ramasauskaite; Isabel Lloyd; Edwin Chandraharan; Suellen Miller; Thomas Burke; Gabriel Ossanan; Javier Andres Carvajal; Isabella Ramos; Maria Antonia Hincapie; Sara Loaiza; Daniela Nasner
Journal:  Int J Gynaecol Obstet       Date:  2022-03       Impact factor: 4.447

8.  Complications of Caesarean delivery part 1: Early complications.

Authors:  Eelin Tan; Timothy Shao Ern Tan; Harvey Eu Leong Teo; Li Ching Lau
Journal:  Ultrasound       Date:  2021-08-27

9.  Treatment of Placenta Increta With High-Intensity Focused Ultrasound Ablation and Leaving the Placenta in situ: A Multicenter Comparative Study.

Authors:  Xiaoping Guan; Xiaoqin Huang; Min Ye; Guohua Huang; Xiao Xiao; Jinyun Chen
Journal:  Front Med (Lausanne)       Date:  2022-04-07

10.  Protrusion of placental tissue through the cervical os as an unusual presentation of placenta accreta: A case report.

Authors:  Anna Marie Pacheco Young; Katelyn Uribe; Angela K Shaddeau
Journal:  Case Rep Womens Health       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.